Brii Biosciences Limited
Brii Biosciences Limited (BRIBF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BRIBF · as of Jun 9, 2026
Key Statistics
Explore Brii Biosciences Limited Data
bribf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
bribf competitorsBRIBF
BCCOY
BXPHF
CLLKF
GNFTF
IPHYFStock Performance
Full HistoryAbout Brii Biosciences Limited
Brii Biosciences Limited established in 2017 and headquartered in Beijing, China, is dedicated to advancing therapeutic solutions for infectious diseases and disorders affecting the central nervous s…
what is brii biosciences limited · bribf stock overview · brii biosciences limited company profile · who is brii biosciences limited ceo · bribf OTC · brii biosciences limited headquarters · brii biosciences limited business segments
About Stock Overview & Key Data
Brii Biosciences Limited (BRIBF) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 21, 2022. As of the latest trading session, BRIBF stock price is $0.23, with a market capitalization of $166.7M. The stock has returned -11.08% over the past 12 months and +23.83% year-to-date.
In fiscal year 2025, Brii Biosciences Limited reported revenue of $18.1M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Brii Biosciences Limited (BRIBF) stock price is $0.23. The stock is traded on OTC under the ticker symbol BRIBF. The 52-week range is $0.15 – $0.26.